The Office of Bridget Bellingar, DO
Seminole, Florida, United States
Walk-in clinic in Pinellas County, Florida
7101 Park St N, Seminole, FL 33777
About The Office of Bridget Bellingar, DO
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
Gilead Sciences
2
Clinical Trials at The Office of Bridget Bellingar, DO
During the past decade, The Office of Bridget Bellingar, DO conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension
2007-05-01
2010-05-01
Terminated
661
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
2006-09-01
2009-08-01
Completed
849
Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin
2012-07-01
2013-05-01
Completed
354
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at The Office of Bridget Bellingar, DO
According to Clinical.Site data, the most researched conditions in "The Office of Bridget Bellingar, DO" are
"Cardiovascular Disease" (2 trials), "Hypertension" (2 trials) and "Hypercholesterolemia" (1 trials). Many other conditions were trialed in "The Office of Bridget Bellingar, DO" in a lesser frequency.
Clinical Trials Intervention Types at The Office of Bridget Bellingar, DO
Most popular intervention types in "The Office of Bridget Bellingar, DO" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Darusentan" (2 trials), "Guanfacine" (2 trials), "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "200mg PF-04950615 (RN316)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Office of Bridget Bellingar, DO
The vast majority of trials in "The Office of Bridget Bellingar, DO" are
5 trials for "All" genders.
Clinical Trials Status at The Office of Bridget Bellingar, DO
Currently, there are NaN active trials in "The Office of Bridget Bellingar, DO".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in The Office of Bridget Bellingar, DO,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in The Office of Bridget Bellingar, DO, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".